In the start of what may be a growing trend among food manufacturers, General Mills (NYSE: GIS ) announced that Original Cheerios will be produced GMO-free. While the actual amount of genetically modified seed used in the manufacture of Original Cheerios is small, the results of the move could be broad-reaching if other food manufacturers follow General Mills' move with efforts to remove GMOs from their own products.
There are some clear obstacles that will slow any massive GMO-free movement from occurring in the next year, but there are nonetheless other cereals produced by General Mills and its competitors like Kellogg� (NYSE: K ) and PepsiCo (NYSE: PEP ) , which make for strong candidates to undergo reformulations that enable the GMO-free label.
Why GMO-free may not catch on quickly
Regardless of the consumer demand for organic and GMO-free food products, major food producers are limited by simple supply chain logistics that make the sourcing of substantial non-GMO ingredients both difficult and costly. The amount of GMO-based products in Original Cheerios is limited to just small amounts of corn starch and sugar, whereas other cereals even under the Cheerios brand would make the necessary large-scale ingredient sourcing difficult.
Hot Safest Companies For 2015: Elan Corporation PLC (ELN)
Elan Corporation, plc (Elan), incorporated in December 1969, is a neuroscience-based biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. Elan�� business focuses on neurodegenerative diseases, such as Alzheimer�� disease and Parkinson�� disease; autoimmune diseases, including MS and Crohn�� disease and neo-epitope based targets for treatments across a range of therapeutic indications. Tysabri is a treatment for MS and Crohn�� disease that the Company markets and distributes with Biogen Idec. On September 16, 2011, Elan sold its EDT business to Alkermes, Inc. In November 2011, Elan launched a collaboration with the University of Cambridge, England, the Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre). On December 21, 2012, the Company completed the demerger of Prothena Corporation plc. In April 2013, it closed the TYSABRI (natalizumab) Collaboration Transaction with Biogen Idec.
Tysabri
Tysabri, which is an alpha-4 integrin inhibitor, is a therapy for MS, a neurological disorder involving central nervous system dysfunction among adults. Tysabri is approved in more than 65 countries. Tysabri is approved in the United States as a monotherapy for relapsing forms of MS, for patients who have had an inadequate response to, or are unable to tolerate, an alternative MS therapy. In the European Union, it is approved for relapsing-remitting MS (RRMS) in adult patients who have failed to respond to beta interferon or have rapidly evolving, severe RRMS. As of December 31, 2011, there were approximately 64,400 patients on Tysabri therapy worldwide.
In June 2011, the European Commission (EC) approved the inclusion of the anti-JCV antibody status as an additional factor in stratifying patients at risk for developing PML in the Summary of Product Characteristics��(SmPC) for Tysabri in the European Union. The Company has developed a two-step ! enzyme-linked immunosorbent assay (ELISA), STRATIFY JCV, with Biogen Idec. The assay detects anti-JCV antibodies in the blood of patients, and is commercially available in Europe. In January 2012, the FDA cleared the assay for commercial use in the United States. As of December 31, 2011, over 80,000 tests had been administered using the assay. Tysabri is marketed and distributed by Elan and Biogen Idec. The Company�� research group, Neotope, is focused on creating monoclonal antibodies based on neo-epitope targets for the treatment of a range of therapeutic indications.
Beta Amyloid Immunotherapies (AIP)
Beta amyloid immunotherapy includes the treatment of Alzheimer�� disease by inducing or enhancing the body�� immune response in order to clear toxic species of beta amyloid from the brain. The AIP includes bapineuzumab (intravenous and subcutaneous delivery) and ACC-001, as well as other compounds. Bapineuzumab is an experimental humanized monoclonal antibody delivered intravenously that is being studied as a treatment for mild to moderate Alzheimer�� disease. It is designed to provide antibodies to beta amyloid directly to the patient (passive immunotherapy).
ELND005, an A� Aggregation Inhibitor
The small molecule ELND005 (Scyllo-inositol) is a beta amyloid anti-aggregation agent. Preclinical data suggest that ELND005 may act through the mechanism of preventing and reversing the fibrilisation of beta amyloid (the aggregation of beta amyloid into clumps of insoluble oligomers). ELND005 may have additional applications in psychiatric indications, such as bipolar disorder. In November 2011, the Company entered into a manufacturing agreement for the supply of the active pharmaceutical ingredient for ELND005 with Lonza Group AG.
Neotope Biosciences Limited
Neotope Biosciences Limited (Neotope) is the Company�� wholly owned subsidiary that focuses on the discovery and development of antibodies to neo-epitope related targ! ets for t! he treatment of a range of indications. It includes amyloidosis, diabetes, cancer and macular degeneration. Neotope�� portfolio of targets includes alpha-synuclein for the potential treatment of synucleinopathies, such as Lewy body dementia and Parkinson�� disease, tau for Alzheimer�� disease and other tauopathies. It also has a program for type 2-diabetes.
Onclave Therapeutics Limited
Elan�� wholly owned subsidiary Onclave Therapeutics Limited (Onclave) was formed to develop assets originating from Elan that have application in oncology related diseases. Onclave�� program, NEOD001, which originated from Neotope, is being investigated for the treatment of AL amyloidosis, which is a fatal disease involving abnormal accumulation of amyloid in organs and tissue. During the year ended December 31, 2011, Onclave filed for orphan drug designation of NEOD001. Onclave�� pipeline includes additional compounds with relevance in diverse cancer indications.
The Company competes with Biogen Idec, Bayer Schering Pharma AG, Bayer Schering Pharma, Merck Serono, Pfizer, Teva Neurosciences, Inc., Sanofi-Aventis and Novartis AG.
Advisors' Opinion:- [By WALLSTCHEATSHEET]
Elan is a biotechnology company that is looking for ways to improve and better the lives of people with neurodegenerative and autoimmune diseases. The stock has struggled over the last couple of years and looks to be comfortable at these prices. Over the last four quarters, investors in the company have been disappointed as earnings have decreased while revenue figures have increased. Relative to its peers and sector, Elan has been a year-to-date performance leader. WAIT AND SEE what Elan does in coming quarters.
- [By Brian Orelli]
Up for sale
After Elan (NYSE: ELN ) failed to convince its shareholders that its new business model was the right one, the biotech company formally put itself up for sale last Friday. - [By Tim Brugger]
Following the denial of an acquisition offer from Royalty Pharma on April 22 equal to $11.25 a share, or less, for all of Elan's (NYSE: ELN ) outstanding shares, a revised offer from Royalty of $12.50 a share has also been rejected, Elan announced today.
- [By Brian Orelli]
Royalty Pharma announced Monday that it's willing increase the $11-per-share offer it made for Elan (NYSE: ELN ) back in February, depending on the result of Elan's buyback.
Top 5 Consumer Service Companies To Own For 2014: Zoetis Inc (ZTS)
Zoetis Inc, incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The primary livestock species are cattle (both beef and dairy), swine, poultry, sheep and fish, and the primary companion animal species are dogs, cats and horses. In February 2014, Benchmark Holdings PLC purchased aquaculture vaccine and development assets from animal health company Zoetis Inc.
The Company�� more than 300 product lines include vaccines, parasiticides, anti-infectives, medicated feed additives and other pharmaceutical products. The Company�� product portfolio also includes businesses, such as diagnostics, genetics, devices and services, such as dairy data management, e-learning and professional consulting. The Company operates in North America, Europe, Africa, Asia, Australia and Latin America.
Advisors' Opinion:- [By Nicole Seghetti]
Another company that's no stranger to diversification is Pfizer (NYSE: PFE ) . The drugmaker acquired several companies during the past few years, but Pfizer is now keen on divesting its non-core businesses. For example, in February, the drugmaker launched an IPO of a minority stake in Zoetis (NYSE: ZTS ) , once Pfizer's animal health business. As the result of a recent exchange offer, Pfizer is completely separated from Zoetis, now the largest stand-alone company fully dedicated to animal health vaccines and medicines.
- [By Jake L'Ecuyer]
Zoetis (NYSE: ZTS) was down as well, falling 5.25 percent to $29.50 percent after the company guided its fiscal year 2014 revenue and EPS below street estimates.
- [By Maxx Chatsko]
Complete spinoff of animal health division
When Pfizer kicked Zoetis (NYSE: ZTS ) out of the nest earlier this year, it held on to 80% of the company. Now the pharmaceutical giant wants to boot its remaining 401 million shares in an effort to boost earnings and focus on pharma. Animal health is an important and steadily growing international industry, but it just doesn't bring the same margins as prescription drugs. That's probably why Pfizer shares rose 3% after announcing plans to unload its massive stake in Zoetis.
Top 5 Consumer Service Companies To Own For 2014: Xylem Inc (XYL)
Xylem Inc. (Xylem), formerly ITT WCO, Inc., incorporated on May 4, 2011, is a provider of equipment and service for water and wastewater applications with a portfolio of products and services addressing the full cycle of water, from collection, distribution and use to the return of water to the environment. It operates in two segments: Water Infrastructure and Applied Water. The Water Infrastructure segment focuses on the transportation, treatment and testing of water, offering a range of products, including water and wastewater pumps, treatment and testing equipment, and controls and systems. Key brands in this segment include Flygt, Wedeco, Godwin Pumps, WTW, Sanitaire, AADI and Leopold. The Applied Water segment encompasses the uses of water and focuses on the residential, commercial, industrial and agricultural markets. The segment�� products include pumps, valves, heat exchangers, controls and dispensing equipment. Key brands in this segment include Goulds Water Technology (Goulds), Bell & Gossett, AC Fire, Standard, Flojet, Lowara, Jabsco and Flowtronex. The Company sells its products in more than 150 countries through a distribution network consisting of its direct sales force and independent channel partners. On October 31, 2011, ITT Corporation completed Spin-off of Xylem, formerly ITT�� water equipment and services businesses. The Spin-off was completed pursuant to the Distribution Agreement, dated as of October 25, 2011, among ITT, Exelis Inc. (Exelis) and Xylem. In July 2012, it acquired MJK Automation A/S. In March 2013, it acquired MultiTrode Pty Ltd.
Water Infrastructure
Water Infrastructure involves the process that collects water from a source and distributes it to users, and then returns the wastewater to the environment. Water Infrastructure serves three applications: transport, treatment and test of water and wastewater for two types of customers: public utilities and industrial facilities. The Transport application includes all of the equipment and s! ervices involved in the movement of water from sources, such as oceans, lakes, rivers and ground water, to treatment facilities, and then to users. It also includes the movement of wastewater from the point of use to a treatment facility and then back into the environment. The Company serves the equipment markets, such as water and wastewater submersible pumps, monitoring controls, and application solutions. With operations on six continents, it also has dewatering rental fleet, serviced with the Company�� Flygt and Godwin brands. In its Water Infrastructure Segment, Transport accounted for approximately 73% of its consolidated revenue during the year ended December 31, 2011. Flygt is the manufacturer of submersible pumps, mixers, and aeration equipment for use in environments, such as water and wastewater treatment, raw water supply, abrasive or contaminated industrial processes, mining and crop irrigation. Flygt products have applications in various markets, including wastewater lift stations, water and wastewater treatment facilities, pressurized sewage systems, oil and gas, steel, mining and leisure markets. Customers include public utility wastewater and clean water treatment facilities, oil and gas platforms, and steel manufacturing companies.
Godwin Pumps is engaged in pump manufacturing. It manufactures, sells, rents and services products that are customized to the specific needs of its clients. Godwin Pumps��products include the fully automatic self-priming Dri-Prime pump, a range of Sub-Prime electric and Heidra hydraulic submersible pumps, Wet-Prime gasoline-powered contractor pumps and a line of generators and portable light towers. Godwin products are primarily used in construction, disaster recovery, flooding, heavy industry, marine use, mining, oil, gas and chemical extraction, refineries, temporary fire protection and water and wastewater transport. Customers include industrial plants, construction contractors, public utility wastewaters and clean water treatment and tr! ansportat! ion facilities, oil, gas and chemical drilling outfits, and refineries. Godwin�� fleet of equipment is rented through 33 United States branches and a global network of distributors. The Treatment application includes equipment and services that treat both water for consumption and wastewater to be returned to the environment. Leopold is the Company�� filtration brand. Disinfection systems, both ultraviolet (UV) and ozone oxidation, treat both public utility drinking water and wastewater, as well as industrial process water, and are provided through its WEDECO brand. Biological treatment systems are key to the treatment of solids in wastewater plants, which is provided through its Sanitaire brand. In its Water Infrastructure Segment, Treatment accounted for approximately 18% of its consolidated net sales in 2011.
The Company�� Sanitaire brand provides biological wastewater treatment solutions for public utility and industrial applications. Sanitaire�� offering includes diffused aeration, sequencing batch reactors, drum filters and state-of-the-art controls. Sanitaire is a brand in diffused aeration, which is a process that introduces air into a liquid, providing an aerobic environment for degradation of organic matter. Principal Sanitaire customers are public utility and industrial wastewater treatment facilities. WEDECO develops chemical-free and environmentally friendly water treatment technologies, including ultraviolet light and ozone systems. There are over 250,000 installed WEDECO systems for UV disinfection and ozone oxidation globally in private, public utility and industrial locations. Customers include public utility wastewater and clean water treatment facilities, power plants, pulp and paper mills, food products manufacturers and aquaculture facilities. Leopold is a gravity media filtration and clarification solutions for the water and wastewater industry. Nova Analytics, its served market is focused on water and the environment for quality levels throughout the water in! frastruct! ure loop.. Analytical systems are applied in three primary ways: in the field, in a facility laboratory, or real time, online monitoring in a treatment facility process. In its Water Infrastructure Segment, Test accounted for approximately 9% of its consolidated net sales in 2011.
In wastewater treatment facilities, WTW-branded systems monitor parameters, such as dissolved oxygen, pH, and turbidity throughout the water process. WTW�� product offering includes meters, sensors, data-loggers, photometers and software. Aanderaa Data Instruments AS (AADI) offers sensors, instruments and systems for measuring and monitoring in environments, such as rivers, oceans and the polar regions through networked systems using wireless technology that monitors temperature, salinity, oxygen, turbidity, current and waves for ecosystem health. The main market areas are marine transportation, environmental and ocean research, oil and gas, aquaculture, road and traffic, and construction. Oceanography International Corporation (OI Analytical) provides products used for chemical analysis. The Company develops, manufactures, sells, and services analytical instruments that detect, measure, analyze, and monitor chemicals in liquids, solids, and gases. Yellow Springs Instrument Company (YSI) develops and manufactures sensors, instruments, software and data collection platforms for environmental and coastal water quality monitoring and testing. YSI also offers life sciences products, including biochemical analyzers for bioprocess monitoring, food and beverage processing, and sports physiology. The main market areas are marine transportation, environmental and ocean research, oil and gas, aquaculture, road and traffic, and construction.
Applied Water
Applied Water encompasses all the uses of water. Its served market consists of the main uses of global water: Building Services, Industrial Water and Irrigation. The Building Services is defined by four main uses of water in building services ! applicatio! ns, such as in residential homes and commercial buildings, including offices, hotels, restaurants and malls. The first is the supply of potable water for consumption, such as for drinking and hygiene. The Goulds brand offers pumps and boosting systems utilized within buildings, sourcing water from distribution networks or from wells. The second application is wastewater removal with sump and sewage pumps. The third application is in heating, ventilation and air conditioning (HVAC), where Bell & Gossett specializes in pumps and valves that are used in water-based heating and cooling systems. The fourth water-related building service area is fire protection, where its AC Fire brand supplies full pump systems for emergency fire suppression. In Europe, Lowara is a brand in the commercial and residential water market with applications in the four main uses of water. In its Applied Water Segment, Building Services accounted for approximately 51% of its consolidated net sales in 2011.
The Company�� Goulds brand supplies vertical multistage pumps to boost pressure for purposes , such as circulating water through a manufacturing facility to cool machine tools. Its Lowara brand focuses on water treatment, industrial washing equipment and machine tool cooling. The Standard brand delivers heat exchangers for combined heat and power (CHP) applications within power generation plants. It also provides applications, such as flexible impeller pumps for wine processing facilities served by its Jabsco brand, and water-based detergent dispensing and water circulation within car washes served by Flojet and Goulds air-operated diaphragm and end suction pumps. In its Applied Water Segment, Industrial Water accounted for approximately 42% of its consolidated net sales in 2011. The irrigation business consists of irrigation-related equipment and services associated with bringing water from a source to the plant or livestock need, including hoses, sprinklers, center pivot and drip irrigation. The Company focuses ! on the pu! mps and boosting systems that supply this ancillary equipment with water. Its Goulds brand brings mixed flow pumps, and its Flowtronex group specializes in equipment solutions, such as the Hydrovar boosting system, which incorporates monitoring and controls. Its Lowara brand also produces pumps for agriculture applications and irrigation of gardens and parks. In its Applied Water Segment, Irrigation accounted for approximately 7% of the Company�� consolidated net sales in 2011.
Advisors' Opinion:- [By Jim Jubak]
I wouldn't exactly call it super enthusiastic guidance, but this quarter, when so few companies have anything good to say about their business for the fourth quarter, even Xylem's (XYL) tepid enthusiasm stands out.
- [By Marc Bastow]
Water and waste-water systems provider Xylem (XYL) raised its quarterly dividend 10% to 12.8 cents per share, payable on Mar. 19 to shareholders of record as of Feb. 19.
XYL Dividend Yield: 1.39% - [By Ben Levisohn]
Stocks received a respite from the selling today as Michael Kors�(KORS), Yum Brands (YUM),�Merck�(MRK),�Pfizer�(PFE) and�Xylem�(XYL) gained.
Top 5 Consumer Service Companies To Own For 2014: Iberdrola SA (IBE)
Iberdrola SA is a Spain-based company principally engaged in the energy sector. The Company's business is structured in four segments: Network Business, including all the energy transmission and distribution activities, and any other regulated activity originated in Spain, the United Kingdom, the United States and Brazil; Deregulated Business, including electricity generation and sales businesses as well as gas trading and storage businesses carried on by the Group in Spain, Portugal, the United Kingdom and North America; Renewable: activities relating to renewable energies in Spain, the United Kingdom, the United States and the rest of the world; Other Businesses, comprising the engineering and construction businesses and the non-power businesses; and Corporation which includes the costs of the Group's structure (Single Corporation), of the administration services of the corporate areas that are subsequently invoiced to the other companies through either specific service. Advisors' Opinion:- [By Sarah Jones]
Iberdrola SA (IBE), Spain�� biggest power company, fell 3.4 percent to 3.87 euros. Endesa SA (ELE) slumped 4.6 percent to 16 euros, while Acciona SA (ANA), which owns more than 4 gigawatts of wind farms in the country, tumbled 8.5 percent to 37.95 euros. Red Electrica Corp. slid 7.5 percent to 38.34 euros.
No comments:
Post a Comment